Clin2
NCT06314087Possibly a fitRecruiting

Personalized cancer vaccine with radiation therapy

Advanced Tumors

Part of Cancer clinical trials.

This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
154 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have advanced or recurrent cancer that standard treatments no longer control
  • You have at least one tumor that can be measured on scans
  • You are able to provide a tumor sample or have DNA data for analysis
  • You have a life expectancy of at least 3 months
  • You are not pregnant and willing to use contraception

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06195293Recruiting· Phase 1
Personalized cancer vaccine for advanced solid tumors

This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.

Guangzhou
NCT07182435Not yet recruiting· Early Phase 1
Personalized mRNA vaccine for advanced solid tumors

This trial tests a personalized mRNA vaccine (RH125) designed to train your immune system to attack your cancer. It is for people with advanced solid tumors that have not responded to standard treatments, and it aims to see if the vaccine is safe and helpful.

Shenzhen, Guangdong
NCT06477614Recruiting· Phase 1
Personalized vaccine for advanced solid tumors

This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to help your body fight advanced cancer. It is for people whose cancer has not responded to other treatments.

Guanzhou, Guangdong
NCT05014607AVAILABLE
Personalized cancer vaccine for advanced cancer

This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.

NCT06756295Not yet recruiting· Early Phase 1
Personalized immune cell therapy plus radiation for advanced cancer

This study tests a personalized treatment that uses your own immune cells, trained to recognize your tumor, combined with radiation therapy. It is for people with advanced cancer that has not responded to standard treatments, and aims to help the body fight the cancer more effectively.

NCT06682117Recruiting
A study of a personalized vaccine for advanced solid tumors

This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.

Shanghai, Shanghai Municipality

Hear when a new Advanced Tumors trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.